Related Experiment Video
Updated: Jan 24, 2026

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
Published on: September 20, 2020
HiPS-Cardiac Trilineage Cell Generation and Transplantation: a Novel Therapy for Myocardial Infarction
Ampadu O Jackson1,2, Huifang Tang3, Kai Yin4,5
1Department of Cardiology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Insights
Human induced pluripotent stem cells (hiPSCs) can regenerate cardiac cells to repair heart damage. This study explores hiPSC-derived cardiac trilineage cells (CTCs) for treating cardiovascular diseases (CVDs).
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Cardiovascular diseases (CVDs) remain a leading cause of mortality, with limited regenerative capacity in the adult heart.
- Despite advancements like primary percutaneous coronary intervention (PPCI) and dual antiplatelet therapy (DAPT), major adverse cardiovascular events (MACEs) persist due to recurrent thrombotic complications and myocardial infarction (MI).
- Myocardial infarction (MI) results in significant loss of endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and cardiomyocytes (CMs), which the adult cardiovascular system struggles to regenerate.
Purpose of the Study:
- To investigate the generation of cardiac trilineage cells (CTCs) from human induced pluripotent stem cells (hiPSCs).
- To elucidate the pathways involved in hiPSC-CTC generation.
- To evaluate the therapeutic potential of hiPSC-derived CTCs in cardiovascular disease treatment.
Main Methods:
- Induction of hiPSCs to differentiate into CTCs in vitro.
- Analysis of the molecular pathways governing hiPSC-CTC differentiation.
- In vivo transplantation of hiPSC-derived CTCs in a preclinical model.
- Assessment of therapeutic effects and myocardial repair post-transplantation.
Main Results:
- Successful in vitro generation of hiPSC-derived CTCs, encompassing ECs, VSMCs, and CMs.
- Identification of key pathways regulating hiPSC-CTC differentiation and maturation.
- Demonstration of in vivo therapeutic effects following transplantation of hiPSC-derived CTCs.
- Evidence of myocardial repair and functional improvement in the treated model.
Conclusions:
- hiPSC-derived CTCs hold significant promise for regenerating damaged cardiovascular tissue.
- Understanding the underlying pathways is crucial for optimizing hiPSC-CTC generation for therapeutic applications.
- This approach offers a novel regenerative medicine strategy for treating cardiovascular diseases (CVDs).
Abstract:
Despite primary percutaneous coronary intervention (PPCI) and the availability of optimal medications, including dual antiplatelet therapy (DAPT), most patients still experience major adverse cardiovascular events (MACEs) due to frequent recurrence of thrombotic complications and myocardial infarction (MI). MI occurs secondary to a massive loss of endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and cardiomyocytes (CMs). The adult cardiovascular system gradually loses the ability to spontaneously and regularly regenerate ECs, VSMCs, and CMs. However, human cells can be induced by cytokines and growth factors to regenerate human-induced pluripotent stem cells (hiPSCs), which progress to produce cardiac trilineage cells (CTCs) such as ECs, VSMCs, and CMs, replacing lost cells and inducing myocardial repair. Nevertheless, the processes and pathways involved in hiPSC-CTC generation and their potential therapeutic effects remain unknown. Herein, we provide evidence of in vitro CTC generation, the pathways involved, in vivo transplantation, and its therapeutic effect, which may provide novel targets in regenerative medicine for the treatment of cardiovascular diseases (CVDs).
Related Concept Videos
Gene Therapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Group Therapy
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Psychodynamic Therapy
Humanistic Therapy

